Jennifer Ku, PhD, MPH

Postdoctoral Research Fellow

Division of Epidemiologic Research



Dr. Ku is an infectious disease epidemiologist and postdoctoral research fellow in the Department of Research & Evaluation. Her research includes vaccine safety and effectiveness projects on shingles and COVID-19 vaccines. She is also involved in other infectious diseases studies on influenza, SARS-CoV-2, and other respiratory viruses.

Before joining Kaiser Permanente in 2021, Dr. Ku worked in clinical and epidemiologic research in a variety of roles at Oregon Health & Science University. During her doctoral training, Dr. Ku also served in a leadership role on the Oregon Health Authority/School of Public Health COVID-19 Pandemic Response Team. Her previous research interests included pulmonary infection due to nontuberculous mycobacteria (NTM), primarily focusing on treatment patterns and outcomes using large health care administrative data. As part of her doctoral dissertation research, Dr. Ku used U.S. Medicare data to understand prescribing patterns and tolerability outcomes of antibiotic therapy for NTM pulmonary disease.

Areas of Focus

  • Infectious diseases
  • Vaccine safety and effectiveness
  • Antimicrobial treatment and resistance
  • Pharmacoepidemiology


PhD, Epidemiology
Oregon Health & Science University
Portland, Oregon
MPH, Epidemiology and Biostatistics
Oregon Health & Science University
Portland, Oregon
BS, Neuroscience
University of Michigan
Ann Arbor, Michigan

Honors and Awards

  • Oregon Health & Science University – Portland State University School of Public Health Student Award for Excellence in Research
  • American Thoracic Society Abstract Award, Assembly on Pulmonary Infections and Tuberculosis